{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:10:10Z","timestamp":1791252610829,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["04X-3874"],"award-info":[{"award-number":["04X-3874"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BAGADILICO program"},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EU 7th Framework project REPLACES"},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.expneurol.2012.02.012","type":"journal-article","created":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T10:00:30Z","timestamp":1330164030000},"page":"306-315","source":"Crossref","is-referenced-by-count":144,"title":["Comparison of the behavioural and histological characteristics of the 6-OHDA and \u03b1-synuclein rat models of Parkinson's disease"],"prefix":"10.1016","volume":"235","author":[{"given":"M.","family":"Decressac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2012.02.012_bb0005","first-page":"II3","article-title":"Pathoanatomy of Parkinson's disease","volume":"247","author":"Braak","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0079-6123(10)84002-6","article-title":"Neurotoxic in vivo models of Parkinson's disease recent advances","volume":"184","author":"Cannon","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0015","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0306-4522(92)90196-9","article-title":"Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum","volume":"46","author":"Cenci","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0025","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0040","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/brain\/awr149","article-title":"GDNF fails to exert neuroprotection in a rat alpha-synuclein model of Parkinson's disease","volume":"134","author":"Decressac","year":"2011","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainresbull.2005.08.009","article-title":"The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum","volume":"68","author":"Dowd","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0050","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in vivo for the ubiquitin\u2013proteasome system and the autophagy\u2013lysosomal pathway in the degradation of {alpha}-synuclein","volume":"31","author":"Ebrahimi-Fakhari","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0055","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/brain\/awp328","article-title":"The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease","volume":"133","author":"Grealish","year":"2010","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1046-2023(02)00219-0","article-title":"Production methods for gene transfer vectors based on adeno-associated virus serotypes","volume":"28","author":"Grimm","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0065","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.0953-816x.2001.01534.x","article-title":"Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease","volume":"13","author":"Kirik","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0075","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0085","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0090","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","article-title":"Genetic mouse models of Parkinson's disease. The state of the art","volume":"184","author":"Magen","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0105","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/exnr.1999.7296","article-title":"Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model","volume":"161","author":"Rosenblad","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0115","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuroscience.2008.03.048","article-title":"Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease","volume":"154","author":"Torres","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneumeth.2011.06.012","article-title":"Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates","volume":"200","author":"Torres","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2012.02.012_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"alpha-Synuclein and dopamine at the crossroads of Parkinson's disease","volume":"33","author":"Venda","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(00)27012-X","article-title":"Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement","volume":"127","author":"Winkler","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.02.012_bb0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T04:53:00Z","timestamp":1561351980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488612000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0014488612000714"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.02.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}